Pepgen Corp

Pepgen Corporation develops biotechnology solutions for drug delivery and disease treatment. The Company leverages its Enhanced Delivery Oligonucleotide platform to create therapies for neuromuscular and neurological diseases, and conducts clinical trials for disease-modifying therapeutics. Pepgen Corp serves individuals living with these conditions in Europe and the United States.